Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 4488.06 | 244 / 245 | 99% | 9.86 | 495 / 502 |
| kidney | 100% | 2280.87 | 89 / 89 | 98% | 11.48 | 879 / 901 |
| lung | 100% | 4094.42 | 576 / 578 | 92% | 8.82 | 1065 / 1155 |
| thymus | 96% | 1920.95 | 629 / 653 | 83% | 5.39 | 504 / 605 |
| esophagus | 87% | 1883.13 | 1259 / 1445 | 87% | 5.32 | 160 / 183 |
| stomach | 99% | 2657.03 | 356 / 359 | 74% | 4.65 | 212 / 286 |
| intestine | 100% | 4680.65 | 966 / 966 | 73% | 3.60 | 386 / 527 |
| bladder | 100% | 5181.57 | 21 / 21 | 72% | 4.37 | 361 / 504 |
| uterus | 95% | 1829.86 | 162 / 170 | 73% | 5.99 | 337 / 459 |
| brain | 81% | 1098.41 | 2132 / 2642 | 82% | 4.82 | 576 / 705 |
| skin | 86% | 1723.28 | 1556 / 1809 | 72% | 4.21 | 342 / 472 |
| breast | 93% | 1500.92 | 426 / 459 | 50% | 2.51 | 564 / 1118 |
| muscle | 100% | 14164.64 | 803 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 4676.49 | 1311 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 94% | 2050.31 | 1136 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 7% | 66.15 | 22 / 328 | 88% | 4.82 | 156 / 178 |
| heart | 93% | 2910.95 | 802 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 4.74 | 38 / 45 |
| spleen | 79% | 955.15 | 191 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 5% | 40.49 | 13 / 258 | 63% | 3.45 | 144 / 230 |
| ovary | 37% | 787.70 | 66 / 180 | 30% | 1.07 | 128 / 430 |
| lymph node | 0% | 0 | 0 / 0 | 66% | 3.08 | 19 / 29 |
| peripheral blood | 63% | 1344.26 | 589 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 46% | 2.01 | 37 / 80 |
| liver | 10% | 103.08 | 22 / 226 | 12% | 0.49 | 49 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1901898 | Biological process | negative regulation of relaxation of cardiac muscle |
| GO_1902514 | Biological process | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
| GO_0086004 | Biological process | regulation of cardiac muscle cell contraction |
| GO_0019933 | Biological process | cAMP-mediated signaling |
| GO_0002027 | Biological process | regulation of heart rate |
| GO_0050852 | Biological process | T cell receptor signaling pathway |
| GO_0032743 | Biological process | positive regulation of interleukin-2 production |
| GO_0045822 | Biological process | negative regulation of heart contraction |
| GO_0032754 | Biological process | positive regulation of interleukin-5 production |
| GO_0061028 | Biological process | establishment of endothelial barrier |
| GO_0032729 | Biological process | positive regulation of type II interferon production |
| GO_0010880 | Biological process | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
| GO_0033137 | Biological process | negative regulation of peptidyl-serine phosphorylation |
| GO_0006198 | Biological process | cAMP catabolic process |
| GO_0106072 | Biological process | negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO_1901844 | Biological process | regulation of cell communication by electrical coupling involved in cardiac conduction |
| GO_0071875 | Biological process | adrenergic receptor signaling pathway |
| GO_0010460 | Biological process | positive regulation of heart rate |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005813 | Cellular component | centrosome |
| GO_0005891 | Cellular component | voltage-gated calcium channel complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0034704 | Cellular component | calcium channel complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0019899 | Molecular function | enzyme binding |
| GO_0004114 | Molecular function | 3',5'-cyclic-nucleotide phosphodiesterase activity |
| GO_0030552 | Molecular function | cAMP binding |
| GO_1901363 | Molecular function | heterocyclic compound binding |
| GO_0005246 | Molecular function | calcium channel regulator activity |
| GO_0030545 | Molecular function | signaling receptor regulator activity |
| GO_0047555 | Molecular function | 3',5'-cyclic-GMP phosphodiesterase activity |
| GO_0097110 | Molecular function | scaffold protein binding |
| GO_0031698 | Molecular function | beta-2 adrenergic receptor binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0044325 | Molecular function | transmembrane transporter binding |
| GO_0051117 | Molecular function | ATPase binding |
| GO_0004115 | Molecular function | 3',5'-cyclic-AMP phosphodiesterase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PDE4D |
| Protein name | Phosphodiesterase 4D Phosphodiesterase (EC 3.1.4.-) 3',5'-cyclic-AMP phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43) (cAMP-specific phosphodiesterase 4D) |
| Synonyms | DPDE3 hCG_1811507 |
| Description | FUNCTION: Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. . |
| Accessions | ENST00000505507.6 D6RIG1 ENST00000505453.1 A0A1B0GW84 ENST00000317118.12 [Q08499-8] D6RAQ0 ENST00000405755.6 [Q08499-9] A0A140VJR0 ENST00000502575.1 [Q08499-12] ENST00000358923.10 [Q08499-5] ENST00000340635.11 [Q08499-1] ENST00000309641.10 [Q08499-7] ENST00000507116.6 [Q08499-6] ENST00000514552.5 D6RBB2 D6R9L4 ENST00000360047.9 [Q08499-2] ENST00000509368.6 D6RHE0 Q08499 ENST00000502484.6 [Q08499-11] ENST00000515835.2 ENST00000503258.5 [Q08499-10] ENST00000636120.1 |